A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Thomas Jefferson University
City of Hope Medical Center
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
Northwestern University
Fred Hutchinson Cancer Center